Literature DB >> 28333256

Analgesia use during pregnancy and risk of cryptorchidism: a systematic review and meta-analysis.

Jason Gurney1, Lorenzo Richiardi2, Katherine A McGlynn3, Virginia Signal1, Diana Sarfati1.   

Abstract

STUDY QUESTION: Are boys who are born to mothers who use analgesics during pregnancy at increased risk of cryptorchidism compared to those born to mothers who do not take analgesia? SUMMARY ANSWER: In this systematic review and meta-analysis of 10 published studies, we observed only weak evidence of an association between analgesia use during pregnancy and risk of cryptorchidism in the son. WHAT IS KNOWN ALREADY: Concentrations of analgesia relevant to human exposure have been implicated as causing endocrine disturbances in the developing foetal testis. However, when viewed collectively there appears to be conflicting evidence regarding an association between maternal use of analgesics and development of cryptorchidism. STUDY DESIGN, SIZE, DURATION: A systematic review and meta-analysis of studies on analgesia use during pregnancy and risk of cryptorchidism was performed. The search terms used were (analges* OR paracetamol OR acetaminophen) AND (cryptorchidism OR cryptorchism OR undescended test* OR non-descended test* OR non descended test*) for the databases Ovid Medline, Embase, Scopus and Web of Science. The search included all published articles up until 23 May 2016 and no limits were set in terms of language. PARTICIPANTS/MATERIALS, SETTING,
METHODS: Abstracts were screened by one reviewer to remove irrelevant studies, with a 10% random sample of these verified by a second reviewer. The full text of all remaining papers was assessed by two reviewers. Abstracts included in the final analysis were studies which reported associations between the exposure (analgesia) and the outcome (cryptorchidism). Studies were only included if data were provided from which summary associations (odds ratios (ORs) or relative risks) and their 95% CIs could be calculated, or if summary associations were provided by the authors themselves. For each included study, two reviewers independently extracted study meta-data in line with PRISMA recommendations. We assessed study quality and potential for bias using the criteria outlined in the Newcastle-Ottawa Quality Assessment Scale, but did not determine a quality score. Two reviewers independently assessed study quality against these criteria. MAIN RESULTS AND THE ROLE OF CHANCE: After screening 350 manuscripts, 10 were included in our review (5 case-control studies, 5 cohort studies). We observed weak evidence of an association between ever use of analgesia and risk of cryptorchidism (pooled crude OR: 1.11, 95% CI: 1.00-1.23), with case-control studies revealing a marginally stronger association (1.23, 95% CI: 0.85-1.78) than cohort studies (1.09, 95% CI: 0.97-1.22). We observed weak evidence of a dose-response relationship between increasing weeks of analgesia exposure and risk of cryptorchidism, as well as weak evidence of an effect of timing on analgesia exposure and risk of cryptorchidism. Assessment of study quality via the Newcastle-Ottawa criteria revealed little (if any) evidence of substantial bias that may have meaningfully affected a given study's results. LIMITATIONS, REASONS FOR CAUTION: While confounding does not appear to be important, misclassification of the exposure is possibly an important source of measurement error in this context. The systematic review is open to reporting bias. Owing to scant data, no meta-analyses for two key questions (relating to dose-response and timing of exposure) could be performed. Medications were grouped based on their common effect and this offers little insight into the relation between specific types of analgesia and cryptorchidism. Finally, there are limitations in assuming that analgesia use reported by mothers is synonymous with actual intrauterine exposure. WIDER IMPLICATIONS OF THE
FINDINGS: The ubiquity of analgesia use during pregnancy makes this exposure particularly important from a population health perspective. About 9 of the 10 studies were conducted in Europe or USA, limiting generalizability of our observations. While the observations from our systematic review and meta-analysis suggest that analgesia use during pregnancy is not strongly associated with cryptorchidism development in the son, they also highlight the need for further detailed assessments of this relationship. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by the Health Research Council of New Zealand (reference #: 14/052). The authors have no conflict of interest to declare. REGISTRATION NUMBER: CRD42016041414.
© The Author 2017. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  analgesia; congenital abnormality; cryptorchidism; cryptorchism; painkiller; paracetamol; pregnancy

Mesh:

Substances:

Year:  2017        PMID: 28333256      PMCID: PMC5808643          DOI: 10.1093/humrep/dex047

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  24 in total

Review 1.  Clinical epidemiology of testicular germ cell tumors.

Authors:  K-P Dieckmann; U Pichlmeier
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

2.  Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: the Generation R Study.

Authors:  Claudia A Snijder; Andreas Kortenkamp; Eric A P Steegers; Vincent W V Jaddoe; Albert Hofman; Ulla Hass; Alex Burdorf
Journal:  Hum Reprod       Date:  2012-02-02       Impact factor: 6.918

3.  Prospective study on the prevalence and associated risk factors of cryptorchidism in 6246 newborn boys from Nice area, France.

Authors:  K Wagner-Mahler; J-Y Kurzenne; I Delattre; E Bérard; J-C Mas; L Bornebush; C Tommasi; M Boda-Buccino; B Ducot; C Boullé; P Ferrari; P Azuar; A Bongain; P Fénichel; F Brucker-Davis
Journal:  Int J Androl       Date:  2011-08-10

4.  Paternity after unilateral cryptorchidism: a controlled study.

Authors:  P A Lee; L A O'Leary; N J Songer; M T Coughlin; M F Bellinger; R E LaPorte
Journal:  Pediatrics       Date:  1996-10       Impact factor: 7.124

5.  Cryptorchidism: a prospective study of 7500 consecutive male births, 1984-8. John Radcliffe Hospital Cryptorchidism Study Group.

Authors: 
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

6.  Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries.

Authors:  K A Boisen; M Kaleva; K M Main; H E Virtanen; A-M Haavisto; I M Schmidt; M Chellakooty; I N Damgaard; C Mau; M Reunanen; N E Skakkebaek; J Toppari
Journal:  Lancet       Date:  2004-04-17       Impact factor: 79.321

7.  Acetaminophen use during pregnancy: effects on risk for congenital abnormalities.

Authors:  Cristina Rebordosa; Manolis Kogevinas; Erzsébet Horváth-Puhó; Bente Nørgård; Maria Morales; Andrew E Czeizel; Hendrik Vilstrup; Henrik T Sørensen; Jørn Olsen
Journal:  Am J Obstet Gynecol       Date:  2008-02       Impact factor: 8.661

8.  Risk factors for undescended testis.

Authors:  T W Davies; D R Williams; R H Whitaker
Journal:  Int J Epidemiol       Date:  1986-06       Impact factor: 7.196

Review 9.  Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography.

Authors:  Simon Sanderson; Iain D Tatt; Julian P T Higgins
Journal:  Int J Epidemiol       Date:  2007-04-30       Impact factor: 7.196

10.  Prevalence of use of non-prescription analgesics in the Norwegian HUNT3 population: Impact of gender, age, exercise and prescription of opioids.

Authors:  Ola Dale; Petter C Borchgrevink; Olav Magnus S Fredheim; Milada Mahic; Pål Romundstad; Svetlana Skurtveit
Journal:  BMC Public Health       Date:  2015-05-02       Impact factor: 3.295

View more
  7 in total

1.  Maternal smoking during pregnancy and risk of cryptorchidism: a systematic review and meta-analysis.

Authors:  Chengjun Yu; Yi Wei; Xiangliang Tang; Bin Liu; Lianju Shen; Chunlan Long; Tao Lin; Dawei He; Shengde Wu; Guanghui Wei
Journal:  Eur J Pediatr       Date:  2018-11-21       Impact factor: 3.183

Review 2.  Intrauterine Exposure to Acetaminophen and Adverse Developmental Outcomes: Epidemiological Findings and Methodological Issues.

Authors:  Zeyan Liew; Andreas Ernst
Journal:  Curr Environ Health Rep       Date:  2021-01-04

3.  Evaluation of safety, efficacy, tolerability, and treatment-related outcomes of type I interferons for human coronaviruses (HCoVs) infection in clinical practice: An updated critical systematic review and meta-analysis.

Authors:  Chengjun Yu; Lian Kang; Jiadong Chen; Na Zang
Journal:  Int Immunopharmacol       Date:  2020-06-25       Impact factor: 4.932

4.  Comparison of Single-Incision Scrotal Orchiopexy and Traditional Two-Incision Inguinal Orchiopexy for Primary Palpable Undescended Testis in Children: A Systematic Review and Meta-Analysis.

Authors:  Chengjun Yu; Yang Hu; Ling Wang; Lian Kang; Jie Zhao; Jiandong Lu; Tao Lin; Dawei He; Shengde Wu; Guanghui Wei
Journal:  Front Pediatr       Date:  2022-03-15       Impact factor: 3.418

5.  Acetaminophen (APAP, Paracetamol) Interferes With the First Trimester Human Fetal Ovary Development in an Ex Vivo Model.

Authors:  Laetitia L Lecante; Sabrina Leverrier-Penna; Thomas Gicquel; Frank Giton; Nathalie Costet; Christèle Desdoits-Lethimonier; Laurianne Lesné; Bernard Fromenty; Vincent Lavoué; Antoine D Rolland; Séverine Mazaud-Guittot
Journal:  J Clin Endocrinol Metab       Date:  2022-05-17       Impact factor: 6.134

6.  Viral infections that alter estrogen levels during pregnancy may contribute to the etiology of cryptorchidism.

Authors:  Faruk Hadziselimovic
Journal:  Basic Clin Androl       Date:  2021-07-08

Review 7.  Endocrine Disrupting Chemicals Interfere With Leydig Cell Hormone Pathways During Testicular Descent in Idiopathic Cryptorchidism.

Authors:  Patrick Fénichel; Nicolas Chevalier; Najiba Lahlou; Patrick Coquillard; Kathy Wagner-Mahler; Michel Pugeat; Patricia Panaïa-Ferrari; Françoise Brucker-Davis
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-10       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.